Return to study ST003898 main page

Download data matrix(Glycosaminoglycan-mediated lipoprotein uptake protects cancer cells from ferroptosis Reversed phase POSITIVE ION MODE)

AnalysisSamplesFactorsUnits
Reversed phase POSITIVE ION MODE9456 (9)Sample Information:VM100_Adjacent Kidneyion count
Reversed phase POSITIVE ION MODE9456 (10)Sample Information:VM100_Primary ccRCCion count
Reversed phase POSITIVE ION MODE9456 (11)Sample Information:VM101_Adjacent Kidneyion count
Reversed phase POSITIVE ION MODE9456 (12)Sample Information:VM101_Primary ccRCCion count
Reversed phase POSITIVE ION MODE9456 (13)Sample Information:VM102_Adjacent Kidneyion count
Reversed phase POSITIVE ION MODE9456 (14)Sample Information:VM102_Primary ccRCCion count
Reversed phase POSITIVE ION MODE9456 (15)Sample Information:VM103_Adjacent Kidneyion count
Reversed phase POSITIVE ION MODE9456 (16)Sample Information:VM103_Primary ccRCCion count
Reversed phase POSITIVE ION MODE9456 (17)Sample Information:VM104_Adjacent Kidneyion count
Reversed phase POSITIVE ION MODE9456 (18)Sample Information:VM104_Primary ccRCCion count
Reversed phase POSITIVE ION MODE9456 (19)Sample Information:VM105_Adjacent Kidneyion count
Reversed phase POSITIVE ION MODE9456 (20)Sample Information:VM105_Primary ccRCCion count
Reversed phase POSITIVE ION MODE9456 (21)Sample Information:VM106_Adjacent Kidneyion count
Reversed phase POSITIVE ION MODE9456 (22)Sample Information:VM106_Primary ccRCCion count
Reversed phase POSITIVE ION MODE9456 (23)Sample Information:VM107_Adjacent Kidneyion count
Reversed phase POSITIVE ION MODE9456 (24)Sample Information:VM107_Primary ccRCCion count
Reversed phase POSITIVE ION MODE9456 (25)Sample Information:VM108_Adjacent Kidneyion count
Reversed phase POSITIVE ION MODE9456 (26)Sample Information:VM108_Primary ccRCCion count
Reversed phase POSITIVE ION MODE9456 (27)Sample Information:VM109_Adjacent Kidneyion count
Reversed phase POSITIVE ION MODE9456 (28)Sample Information:VM109_Primary ccRCCion count
Reversed phase POSITIVE ION MODE9456 (29)Sample Information:VM110_Adjacent Kidneyion count
Reversed phase POSITIVE ION MODE9456 (30)Sample Information:VM110_Primary ccRCCion count
Reversed phase POSITIVE ION MODE9456 (31)Sample Information:VM111_Adjacent Kidneyion count
Reversed phase POSITIVE ION MODE9456 (32)Sample Information:VM111_Primary ccRCCion count
Reversed phase POSITIVE ION MODE9456 (33)Sample Information:VM112_Adjacent Kidneyion count
Reversed phase POSITIVE ION MODE9456 (34)Sample Information:VM112_Primary ccRCCion count
Reversed phase POSITIVE ION MODEB4 (1)Sample Information:VM91_Adjacent Kidneyion count
Reversed phase POSITIVE ION MODEB4 (2)Sample Information:VM91_Primary ccRCCion count
Reversed phase POSITIVE ION MODEB4 (3)Sample Information:VM92_Adjacent Kidneyion count
Reversed phase POSITIVE ION MODEB4 (4)Sample Information:VM92_Primary ccRCCion count
Reversed phase POSITIVE ION MODEB4 (5)Sample Information:VM94_Adjacent Kidneyion count
Reversed phase POSITIVE ION MODEB4 (6)Sample Information:VM94_Primary ccRCCion count
Reversed phase POSITIVE ION MODE9456 (1)Sample Information:VM95_Adjacent Kidneyion count
Reversed phase POSITIVE ION MODE9456 (2)Sample Information:VM95_Primary ccRCCion count
Reversed phase POSITIVE ION MODE9456 (3)Sample Information:VM96_Adjacent Kidneyion count
Reversed phase POSITIVE ION MODE9456 (4)Sample Information:VM96_Primary ccRCCion count
Reversed phase POSITIVE ION MODE9456 (5)Sample Information:VM97_Adjacent Kidneyion count
Reversed phase POSITIVE ION MODE9456 (6)Sample Information:VM97_Primary ccRCCion count
Reversed phase POSITIVE ION MODE9456 (7)Sample Information:VM98_Adjacent Kidneyion count
Reversed phase POSITIVE ION MODE9456 (8)Sample Information:VM98_Primary ccRCCion count
  logo